1. Home
  2. TLPH vs RDHL Comparison

TLPH vs RDHL Comparison

Compare TLPH & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLPH
  • RDHL
  • Stock Information
  • Founded
  • TLPH 2005
  • RDHL 2009
  • Country
  • TLPH United States
  • RDHL Israel
  • Employees
  • TLPH N/A
  • RDHL N/A
  • Industry
  • TLPH Biotechnology: Pharmaceutical Preparations
  • RDHL Biotechnology: Pharmaceutical Preparations
  • Sector
  • TLPH Health Care
  • RDHL Health Care
  • Exchange
  • TLPH Nasdaq
  • RDHL Nasdaq
  • Market Cap
  • TLPH 15.7M
  • RDHL 13.1M
  • IPO Year
  • TLPH 2011
  • RDHL N/A
  • Fundamental
  • Price
  • TLPH $0.78
  • RDHL $8.16
  • Analyst Decision
  • TLPH Strong Buy
  • RDHL
  • Analyst Count
  • TLPH 2
  • RDHL 0
  • Target Price
  • TLPH $4.50
  • RDHL N/A
  • AVG Volume (30 Days)
  • TLPH 85.2K
  • RDHL 40.1K
  • Earning Date
  • TLPH 11-06-2024
  • RDHL 10-15-2024
  • Dividend Yield
  • TLPH N/A
  • RDHL N/A
  • EPS Growth
  • TLPH N/A
  • RDHL N/A
  • EPS
  • TLPH N/A
  • RDHL N/A
  • Revenue
  • TLPH $398,000.00
  • RDHL $3,707,000.00
  • Revenue This Year
  • TLPH N/A
  • RDHL $224.90
  • Revenue Next Year
  • TLPH N/A
  • RDHL $82.69
  • P/E Ratio
  • TLPH N/A
  • RDHL N/A
  • Revenue Growth
  • TLPH 57.31
  • RDHL N/A
  • 52 Week Low
  • TLPH $0.43
  • RDHL $6.43
  • 52 Week High
  • TLPH $1.61
  • RDHL $82.00
  • Technical
  • Relative Strength Index (RSI)
  • TLPH 36.51
  • RDHL 40.13
  • Support Level
  • TLPH $0.75
  • RDHL $7.95
  • Resistance Level
  • TLPH $0.99
  • RDHL $9.05
  • Average True Range (ATR)
  • TLPH 0.08
  • RDHL 0.61
  • MACD
  • TLPH -0.01
  • RDHL -0.20
  • Stochastic Oscillator
  • TLPH 22.22
  • RDHL 6.73

About TLPH Talphera Inc.

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

Share on Social Networks: